DrugPatentWatch Database Preview

DAYTRANA Drug Profile

« Back to Dashboard

Which patents cover Daytrana, and what generic alternatives are available?

Daytrana is a drug marketed by Noven Pharms Inc and is included in one NDA. There are three patents protecting this drug and one Paragraph IV challenge.

This drug has one patent family member in one country.

The generic ingredient in DAYTRANA is methylphenidate. There are thirty-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methylphenidate profile page.

Summary for DAYTRANA

International Patents:	1
US Patents:	3
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	18
Clinical Trials:	13
Patent Applications:	4,492
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for DAYTRANA
Drug Sales Revenues:	Drug sales revenues for DAYTRANA
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for DAYTRANA
DailyMed Link:	DAYTRANA at DailyMed

Pharmacology for DAYTRANA

Drug Class	Central Nervous System Stimulant
Physiological Effect	Central Nervous System Stimulation

Medical Subject Heading (MeSH) Categories for DAYTRANA

Central Nervous System Stimulants

Dopamine Uptake Inhibitors

Synonyms for DAYTRANA

.alpha.-Phenyl-2-piperidineacetic acid methyl ester

113-45-1

2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester

2-Piperidineacetic acid, alpha-phenyl-, methyl ester

298-59-9 (hydrochloride)

4311/B Ciba

AB01563134_01

AC1L1HJM

AKOS022506757

alpha-Phenyl-2-piperidineacetic acid methyl ester

alpha-Phenyl-alpha-(2-piperidyl)acetic acid methyl ester

API0008866

BCP18286

BDBM50062912

BRD-A19585813-003-01-7

C 4311

C07196

Calocain

Centedein

Centedein (Salt/Mix)

Centedrin (Salt/Mix)

Centedrine (Salt/Mix)

Centredin

CHEBI:84276

CHEMBL796

Concerta

Concerta, Methylin, Ritalin

Cotempla XR-ODT

CS-4657

d-methylphenidate HCl

D04999

Daytrana (TN)

DB00422

DEA No. 1724

DTXSID5023299

DUGOZIWVEXMGBE-UHFFFAOYSA-N

EINECS 204-028-6

FT-0700534

GTPL7236

HSDB 3126

HY-B1091

Jornay PM (a.k.a. HLD200)

L001307

LS-565

Meridil

Metadate

Metadate ER

Methyl .alpha.-phenyl-.alpha.-(2-piperidyl)acetate

Methyl .alpha.-phenyl-.alpha.-2-piperidinylacetate

Methyl .alpha.-phenyl-2-piperidine-acetate

Methyl .alpha.-phenyl-2-piperidineacetate

Methyl (2-phenyl-2-(2-piperidyl)acetate)

Methyl 2-phenyl-2-(piperidin-2-yl)acetate

methyl 2-phenyl-2-piperidin-2-ylacetate

Methyl alpha-phenyl-alpha-(2-piperidyl)acetate

Methyl alpha-phenyl-alpha-2-piperidinylacetate

methyl alpha-piperid-2-ylphenylacetate

Methyl phenidate

Methyl phenidyl acetate

Methyl phenidylacetate

Methyl phenyl(2-piperidinyl)acetate #

methyl phenyl(piperidin-2-yl)acetate

Methylfenidan

Methylin

Methylin (Salt/Mix)

Methylin ER

Methylofenidan

Methylphen

Methylphenidan

methylphenidate

METHYLPHENIDATE (SEE ALSO: METHYLPHENIDATE HYDROCHLORIDE, CAS 298-59-9, NTPNO 10266-R)

Methylphenidate (USAN/INN)

Methylphenidate [INN:BAN]

Methylphenidate [USAN:INN:BAN]

Methylphenidate HCl

Methylphenidatum

Methylphenidatum [INN-Latin]

Methylphenidylacetate hydrochloride

MethyPatch

Metilfenidato

Metilfenidato [INN-Spanish]

Metilfenidato [Italian]

NCGC00248587-01

NCI-C56280

Phenidylate

phenyl-piperidin-2-yl-acetic acid methyl ester

Plimasine

PMS-Methylphenidate

Riphenidate

Ritalin

Ritalin (Salt/Mix)

Ritalin LA

Ritaline

Ritaline (Salt/Mix)

Ritcher works

Rubifen

SBI-0206868.P001

SCHEMBL37178

Tsentedrin

US Patents and Regulatory Information for DAYTRANA

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Noven Pharms Inc	DAYTRANA	methylphenidate	FILM, EXTENDED RELEASE;TRANSDERMAL	021514-001	Apr 6, 2006		RX	Yes	No
Noven Pharms Inc	DAYTRANA	methylphenidate	FILM, EXTENDED RELEASE;TRANSDERMAL	021514-003	Apr 6, 2006		RX	Yes	No
Noven Pharms Inc	DAYTRANA	methylphenidate	FILM, EXTENDED RELEASE;TRANSDERMAL	021514-002	Apr 6, 2006		RX	Yes	No
Noven Pharms Inc	DAYTRANA	methylphenidate	FILM, EXTENDED RELEASE;TRANSDERMAL	021514-004	Apr 6, 2006		RX	Yes	Yes			Y
Noven Pharms Inc	DAYTRANA	methylphenidate	FILM, EXTENDED RELEASE;TRANSDERMAL	021514-003	Apr 6, 2006		RX	Yes	No			Y
Noven Pharms Inc	DAYTRANA	methylphenidate	FILM, EXTENDED RELEASE;TRANSDERMAL	021514-001	Apr 6, 2006		RX	Yes	No			Y
Noven Pharms Inc	DAYTRANA	methylphenidate	FILM, EXTENDED RELEASE;TRANSDERMAL	021514-001	Apr 6, 2006		RX	Yes	No			Y

Expired US Patents for DAYTRANA

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Noven Pharms Inc	DAYTRANA	methylphenidate	FILM, EXTENDED RELEASE;TRANSDERMAL	021514-002	Apr 6, 2006
Noven Pharms Inc	DAYTRANA	methylphenidate	FILM, EXTENDED RELEASE;TRANSDERMAL	021514-002	Apr 6, 2006
Noven Pharms Inc	DAYTRANA	methylphenidate	FILM, EXTENDED RELEASE;TRANSDERMAL	021514-004	Apr 6, 2006
Noven Pharms Inc	DAYTRANA	methylphenidate	FILM, EXTENDED RELEASE;TRANSDERMAL	021514-001	Apr 6, 2006
Noven Pharms Inc	DAYTRANA	methylphenidate	FILM, EXTENDED RELEASE;TRANSDERMAL	021514-003	Apr 6, 2006
Noven Pharms Inc	DAYTRANA	methylphenidate	FILM, EXTENDED RELEASE;TRANSDERMAL	021514-003	Apr 6, 2006
Noven Pharms Inc	DAYTRANA	methylphenidate	FILM, EXTENDED RELEASE;TRANSDERMAL	021514-004	Apr 6, 2006

Paragraph IV (Patent) Challenges for DAYTRANA

Drugname	Dosage	Strength	RLD	Date
	Transdermal System	10 mg/9 hrs, 15 mg/9 hrs, 20 mg/9 hrs and 30 mg/9 hrs

International Patents for DAYTRANA

Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2006041911